Tags

Type your tag names separated by a space and hit enter

TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor.
J Cell Physiol. 2005 May; 203(2):345-52.JC

Abstract

Transforming growth factor (TGF-beta1) is a potent inducer of chondrogenesis and stimulant of cartilage extracellular matrix (ECM) synthesis. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is located in ECM and is the major inhibitor of matrix metalloproteinases (MMPs) and aggrecanase, the principal enzymes implicated in collagen and aggrecan degradation in arthritis. We investigated the role of extracellular-signal-regulated kinase (ERK)-mitogen-activated protein kinases (MAPK) and Sp1 transcription factor in TGF-beta-induced TIMP-3 gene in chondrocytes and chondrosarcoma cells. TGF-beta time-dependently induced a sustained phosphorylation of ERK-MAPKs in primary human or bovine chondrocytes. Inhibitors of this pathway, PD98059 and U0126, downregulated TGF-beta-induced expression of TIMP-3 RNA and protein. Since the ERKs can phosphorylate Sp1, and the promoter of human TIMP-3 gene contains four Sp1-binding sites, we investigated whether Sp1 is a downstream target of this pathway. Mithramycin and WP631, the agents that prevent binding of Sp1 to its consensus site, downregulated TGF-beta-inducible TIMP-3 expression. Indeed, mithramycin blocked TGF-beta-stimulated Sp1 binding activity. Transfection of cytomegalovirus (CMV) promoter-Sp1 plasmid increased TIMP-3 promoter (-940 to +376)-driven luciferase activity. Depletion of Sp1 by transfection of an antisense phosphorothioate oligonucleotide suppressed TGF-beta-induced TIMP-3 protein expression, while its sense homolog had no effect. These results suggest that activation of ERK-MAPK pathway and Sp1 transcription factor play a pivotal role in the induction of TIMP-3 by TGF-beta in chondrocytes.

Authors+Show Affiliations

Department of Medicine and Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15468069

Citation

Qureshi, Hamid Yaqoob, et al. "TGF-beta-induced Expression of Tissue Inhibitor of Metalloproteinases-3 Gene in Chondrocytes Is Mediated By Extracellular Signal-regulated Kinase Pathway and Sp1 Transcription Factor." Journal of Cellular Physiology, vol. 203, no. 2, 2005, pp. 345-52.
Qureshi HY, Sylvester J, El Mabrouk M, et al. TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J Cell Physiol. 2005;203(2):345-52.
Qureshi, H. Y., Sylvester, J., El Mabrouk, M., & Zafarullah, M. (2005). TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. Journal of Cellular Physiology, 203(2), 345-52.
Qureshi HY, et al. TGF-beta-induced Expression of Tissue Inhibitor of Metalloproteinases-3 Gene in Chondrocytes Is Mediated By Extracellular Signal-regulated Kinase Pathway and Sp1 Transcription Factor. J Cell Physiol. 2005;203(2):345-52. PubMed PMID: 15468069.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. AU - Qureshi,Hamid Yaqoob, AU - Sylvester,Judith, AU - El Mabrouk,Mohammed, AU - Zafarullah,Muhammad, PY - 2004/10/7/pubmed PY - 2005/6/2/medline PY - 2004/10/7/entrez SP - 345 EP - 52 JF - Journal of cellular physiology JO - J Cell Physiol VL - 203 IS - 2 N2 - Transforming growth factor (TGF-beta1) is a potent inducer of chondrogenesis and stimulant of cartilage extracellular matrix (ECM) synthesis. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is located in ECM and is the major inhibitor of matrix metalloproteinases (MMPs) and aggrecanase, the principal enzymes implicated in collagen and aggrecan degradation in arthritis. We investigated the role of extracellular-signal-regulated kinase (ERK)-mitogen-activated protein kinases (MAPK) and Sp1 transcription factor in TGF-beta-induced TIMP-3 gene in chondrocytes and chondrosarcoma cells. TGF-beta time-dependently induced a sustained phosphorylation of ERK-MAPKs in primary human or bovine chondrocytes. Inhibitors of this pathway, PD98059 and U0126, downregulated TGF-beta-induced expression of TIMP-3 RNA and protein. Since the ERKs can phosphorylate Sp1, and the promoter of human TIMP-3 gene contains four Sp1-binding sites, we investigated whether Sp1 is a downstream target of this pathway. Mithramycin and WP631, the agents that prevent binding of Sp1 to its consensus site, downregulated TGF-beta-inducible TIMP-3 expression. Indeed, mithramycin blocked TGF-beta-stimulated Sp1 binding activity. Transfection of cytomegalovirus (CMV) promoter-Sp1 plasmid increased TIMP-3 promoter (-940 to +376)-driven luciferase activity. Depletion of Sp1 by transfection of an antisense phosphorothioate oligonucleotide suppressed TGF-beta-induced TIMP-3 protein expression, while its sense homolog had no effect. These results suggest that activation of ERK-MAPK pathway and Sp1 transcription factor play a pivotal role in the induction of TIMP-3 by TGF-beta in chondrocytes. SN - 0021-9541 UR - https://www.unboundmedicine.com/medline/citation/15468069/TGF_beta_induced_expression_of_tissue_inhibitor_of_metalloproteinases_3_gene_in_chondrocytes_is_mediated_by_extracellular_signal_regulated_kinase_pathway_and_Sp1_transcription_factor_ L2 - https://doi.org/10.1002/jcp.20228 DB - PRIME DP - Unbound Medicine ER -